باب
Levocabastine
رقم CAS
Levocabastine STD-79516-68-0; 79547-78-7(HCl Salt): IMP-A-1348822-76-3: IMP-B-NA: IMP-E-NA: IMP-J-NA: IMP-K-NA
الصيغة الجزيئية
Levocabastine STD-C26H29FN2O2: IMP-A-C26H30N2O2: IMP-B-C26H29FN2O2: IMP-E-C26H29FN2O2: IMP-J-C26H29FN2O3: IMP-K-C25H24FN2+
وزن جزيئي
Levocabastine STD-420.53: IMP-A-402.54: IMP-B-420.53: IMP-E-420.53: IMP-J-436.53: IMP-K-371.48
مرادف

Levocabastine STD-(3S,4R)-1-[4-cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenylpiperidine-4-carboxylic acid; (3S,4R)-1-((1s,4R)-4-Cyano-4-(4-fluorophenyl)cyclohexyl)-3-methyl-4-phenylpiperidine-4-carboxylic Acid; (3S,4R)-Cabastine Hydrochloride; Levophta; Levostin

Levocabastine-EP-Impurity-A- (3S,4R)-1-(cis-4-cyano-4-phenylcyclohexyl)-3-methyl-4-
phenylpiperidine-4-carboxylic acid

Levocabastine-EP-Impurity-B- (3S,4R)-1-[cis-4-cyano-4-(2-fluorophenyl)cyclohexyl]-3-methyl-4-phenylpiperidine-4-carboxylic acid

Levocabastine-EP-Impurity-E- (3S,4R)-1-[trans-4-cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenylpiperidine-4-carboxylic acid

Levocabastine-EP-Impurity-J- (3S,4R)-1-[cis-4-cyano-4-(4-fluorophenyl)cyclohexyl]-4-(3-
hydroxyphenyl)-3-methylpiperidine-4-carboxylic acid

Levocabastine-EP-Impurity-K-1-[cis-4-cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl4-phenylpyridinium

slide.1
Purity:

Above - 95.0%

Technical Data:

We will provide complete documentation support for every Standard Material. All analytical reports such as ¹H NMR, ¹³C NMR, Mass, FT-IR, HPLC Purity/GC Purity/QNMR Purity, Water content by KF/ Loss on Drying/TGA (Thermo-gravimetric Analysis). Certificate of Analysis with potency report. Each Standard Material SER (Structure Elucidation Report) with NMR, Mass, IR spectral interpretation. This whole analytical document can be included in eCTD, ANDA, DMF submissions to regulatory agencies.

Levocabastine for System Suitability 1 CRS is a certified reference substance used in analytical laboratories to verify the performance of chromatographic systems. It ensures accurate retention time, resolution, and peak shape during testing, confirming that the system is suitable for the reliable and reproducible analysis of levocabastine in pharmaceutical formulations.